

LONDON, April 7 (Reuters) - Pharmaceutical firm Shire said on Tuesday it had agreed with U.S. regulators the steps it would take to submit a candidat...


** Drugmaker's shares jumps 47 pct to $24.72 premarket, levels not hit since the turn of the millennium ** Dyax's lead experimental drug, DX-2930, was...


Carnival topped the risers as strong first-quarter results prompted a lift in full year earnings guidance. It boasted that advance bookings for the re...